Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Pain|June 17, 2023
Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016Shailina Keshwani, Steven M Smith, Joshua Brown, et al.American Journal of Epidemiology|March 18, 2026
A new tool for pregnancy research: a unified definition for major congenital malformation across ICD erasThuy N Thai, Nicole E Smolinski, Sonja A Rasmussen, et al.American Journal of Obstetrics and Gynecology|January 15, 2022
Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation StrategiesAmir Sarayani, Yasser Albogami, Thuy Nhu Thai, et al.Pharmacoepidemiology and Drug Safety|January 18, 2026
Neonatal Outcome Ascertainment in Mother-Infant Paired ClaimsYehua Wang, Nicole E Smolinski, Thuy N Thai, et al.American Journal of Obstetrics and Gynecology|October 14, 2022
Risk of fetal or neonatal death or neonatal intensive care unit admission associated with gadolinium magnetic resonance imaging exposure during pregnancyAlmut G Winterstein, Thuy N Thai, Sabina Nduaguba, et al.Medical Cannabis and Cannabinoids|June 1, 2023
Protocol of a Combined Cohort and Cross-Sectional Study of Persons Receiving Medical Cannabis in Florida, USA: The Medical Marijuana and Me (M<sup>3</sup>) StudyRuba Sajdeya, Hannah J Fechtel, Gabriel Spandau, et al.American Journal of Epidemiology|September 22, 2024
Development and Validation of an Algorithm to Predict Stillbirth Gestational Age in Medicaid Billing RecordsThuy N Thai, Nicole E Smolinski, Sabina Nduaguba, et al.Drug Safety|April 17, 2026
Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) ToolYanning Wang, Celeste L Y Ewig, Nicole E Smolinski, et al.Drug Safety|November 5, 2024
Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk MitigationAlmut G Winterstein, Celeste L Y Ewig, Yanning Wang, et al.Drug Safety|August 5, 2025
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation StrategiesCeleste L Y Ewig, Yanning Wang, Nicole E Smolinski, et al.Pageof 2